GSK Aktie 119642297 / GB00BN7SWP63
15.99
CHF
-0.38
CHF
-2.32%
18:00:00
BRX
| Kurse + Charts + Realtime | News + Analysen | Fundamental | Unternehmen | zugeh. Wertpapiere | Aktion | |
|---|---|---|---|---|---|---|
| Kurs + Chart | Chart (gross) | News + Adhoc | Bilanz/GuV | Termine | Strukturierte Produkte | Portfolio |
| Times + Sales | Chartvergleich | Analysen | Schätzungen | Profil | Watchlist | |
| Börsenplätze | Realtime Push | Kursziele | Dividende/GV | |||
| Orderbuch | Analysen | |||||
| Historisch | Ausblick | |||||
Kurse + Charts + Realtime
News + Analysen
Fundamental
zugeh. Wertpapiere
Aktionärsstruktur
| Inhaber | in % |
|---|---|
| Freefloat | 96.23 |
| The Vanguard Group, Inc. | 3.58 |
| BlackRock Fund Advisors | 3.03 |
| Government Pension Fund - Global (The) | 2.83 |
| Norges Bank Investment Management | 2.30 |
| Schroder Investment Management Ltd. | 1.73 |
| Dodge & Cox International Stock Fund | 1.65 |
| Silchester International Investors LLP | 1.63 |
| BlackRock Advisors (UK) Ltd. | 1.51 |
| Legal & General Investment Management Ltd. | 1.33 |
| Vanguard Total International Stock Index Fund | 1.30 |
| SIX SIS Ltd. | 1.26 |
| SSgA Funds Management, Inc. | 1.19 |
| Mondrian Investment Partners Ltd. | 1.16 |
| Clearstream Banking SA | 1.03 |
*Die Summe der Anteile kann 100% überschreiten, da bestimmte Anteilseigner zum Freefloat dazu gerechnet wurden.
Personal
| 2018 | 2019 | 2020 | 2021 | |
|---|---|---|---|---|
| Personal am Ende des Jahres | 95'490 | 99'437 | 94'066 | 90'096 |
| Umsatz pro Mitarbeiter in Mio. EUR | 0.32 | 0.34 | 0.36 | 0.38 |
Bilanz (in Mio. EUR) - Aktiva
| 2018 | 2019 | 2020 | 2021 | |
|---|---|---|---|---|
| Summe Umlaufvermögen | 16'927 | 19'491 | 20'247 | 18'674 |
| Summe Anlagevermögen | 30'424 | 41'913 | 41'737 | 39'228 |
| Summe Aktiva | 58'066 | 79'692 | 80'431 | 79'103 |
Bilanz (in Mio. EUR) - Passiva
| 2018 | 2019 | 2020 | 2021 | |
|---|---|---|---|---|
| Gesamtverschuldung/ -verbindlichkeiten | 26'064 | 30'508 | 27'150 | 24'173 |
| Summe Fremdkapital | 54'394 | 61'335 | 59'623 | 57'761 |
| Summe Eigenkapital | 3'672 | 18'357 | 20'808 | 21'342 |
| Summe Passiva | 58'066 | 79'692 | 80'431 | 79'103 |
Adresse
| 980 Great West Road, TW8 9GS Middlesex | |
| Telefon | +44 (20) 8047-5000 |
| Fax | +44 (20) 8047-7807 |
| URL | http://gsk.com |
Management
|
Abhishek Agrawal
Director-Strategic Account |
|
Amy Altshul
SVP-Legal, Research & Development |
|
Anita Kidgell
Head-Corporate Strategy |
|
Anne C. Beal
Independent Non-Executive Director |
|
Anne-Marie Martin
Senior VP & Global Head-Experimental Medicine Unit |
|
Brian James McNamara
Chief Executive Officer-Consumer Healthcare |
|
Charles A. Bancroft
Senior Independent Non-Executive Director |
|
Christopher Corsico
Senior Vice President-Development |
|
Claire Lund
Head-Environmental Sustainability |
|
David Simon Redfern
Chief Strategy Officer |
|
Deborah Jayne Waterhouse
Member-Executive Board |
|
Diana Conrad
Chief People Officer |
|
Dipal Patel
Head-Global Commercial |
|
Elizabeth McKee Anderson
Non-Executive Director |
|
Emma N. Walmsley
Chief Executive Officer & Executive Director |
|
Hal V. Barron
Non-Independent Non-Executive Director |
|
Harry C. Dietz
Independent Non-Executive Director |
|
Iain James Mackay
Chief Financial Officer & Executive Director |
|
James Ford
Group General Counsel, Head-Legal & Compliance |
|
Jesse L. Goodman
Independent Non-Executive Director |
|
Jon Ellis
VP & Head-Technology Business Development |
|
Jonathan Richard Symonds
Non-Executive Chairman |
|
Kapila Ratnam
Principal Investigator |
|
Kevin Sin
SVP & Head-Worldwide Business Development |
|
Luke Miels
Chief Commercial Officer |
|
Marc Jones
Senior Vice President-Regional Pharma Supply |
|
María Cristina de Luna Basagoiti
Chairman & General Manager-Spain |
|
Maya Martinez-Davis
President-US Pharmaceuticals |
|
Neil Barnes
Global Franchise Medical Head-Respiratory |
|
Philip Thomson
President-Global Affairs |
|
Regis Jean-Pierre Simard
President-Pharmaceutical Supply Chain |
|
Roger Connor
President-Vaccines & Global Health |
|
Sarah-Jane Hall
Group Treasurer & Senior Vice President |
|
Shobie Ramakrishnan
Chief Digital & Technology Officer |
|
Sonya Ghobrial
Head-Consumer Healthcare Investor Relations |
|
Tony Wood
Chief Scientific Officer |
|
Urs Rohner
Independent Non-Executive Director |
|
Victoria A. Whyte
Secretary |
|
Vishal Sikka
Non-Executive Director |
